Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: KVUE )

21.85 -0.14 (-0.64%)
Official Closing Price Updated: 7:00 PM EDT, Oct 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about KVUE

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
P/E Ratio Insights for Kenvue
Via Benzinga
There are signs that NYSE:KVUE may be ready to breakout.
KENVUE INC is setting up nicely for a breakout. 
Via Chartmill
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks... 
Via Benzinga
Analyst Ratings For Kenvue
Via Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win. 
Via Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
Via The Motley Fool
Decoding 5 Analyst Evaluations For Kenvue
Via Benzinga
Kenvue Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets. 
Via Benzinga
Topics Stocks
Exposures US Equities
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster than regular tablets. A federal judge ruled the claims were preempted by FDA... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
Donald Trump Owns These 21 Dividend Kings. Should You?
Some of Trump's Dividend Kings deserve a crown more than others. 
Via The Motley Fool
Topics Government
Exposures Political
A Big CEO Move, Big Buffett Buys, and More
Motley Fool analysts talk over market news including earnings updates from Home Depot, Walmart, and Brinker. 
Via The Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
ETFs offer a good way to own a diversified portfolio of income-producing equities. 
Via The Motley Fool
Topics ETFs
7 Stable Dividend Stocks to Scoop Up on Discount
The market is looking shaky. To help calm your nerves and sleep easier at night, consider adding these stable dividend stocks to your holdings. 
Via InvestorPlace
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, Aspen Tech, Uber. 
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in August
These longtime winners still have a lot to offer. 
Via The Motley Fool
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
Exposures US Equities
The 7 Best Under $20 Stocks to Buy in August 2024
Although cheap stocks are often cheap for a reason, it doesn't hold true for the best stocks under $20, which is where investors can profit. 
Via InvestorPlace
Kenvue (KVUE) Q2 2024 Earnings Call Transcript
KVUE earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Kenvue News: Why Investors Are Loving KVUE Stock This Week
Kenvue investors are seeing a nice 14% pop in KVUE stock today, after the company reported second quarter earnings that beat on both lines. 
Via InvestorPlace
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
KVUE Stock Earnings: Kenvue Beats EPS, Beats Revenue for Q2 2024
KVUE stock results show that Kenvue beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Listerine-Maker Kenvue's Stock Soars On Strong Q2 Sales From Its Essential Health Unit, Reaffirms Annual Guidance
Kenvue sees stock rise following strong Q2 2024 results. Despite a slight dip in sales, revenue of $4 billion beat expectations. The company's iconic brands and strategic price actions contributed to... 
Via Benzinga
All It Takes Is $10,000 Invested in Coca-Cola and Each of These 2 Dividend Kings to Generate Over $1,000 in Passive Income per Year
Constructing a portfolio that is built to last requires investing in quality companies, purposeful allocation, and diversification. 
Via The Motley Fool
4 Top Dividend Stocks Yielding Over 4% to Buy Hand Over Fist Right Now for Decades of Passive Income
These companies offer high-yielding dividends that should continue rising. 
Via The Motley Fool
7 Long-Term Stocks to Buy on the Dip: July 2024
As investors begin to rotate out of tech stocks, it's time to look at these long-term stocks that are trading at an inviting discount. 
Via InvestorPlace
3 Dividend Stocks to Buy at a 52-Week Low
Discover income and growth opportunities in undervalued dividend stocks, including Kenvue, Telus Corporation and Kraft Heinz. 
Via InvestorPlace
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
If the long-awaited sector rotation is happening, it’s time to look at these undervalued consumer staples stocks. 
Via InvestorPlace
3 Blue-Chip Stocks to Buy for Christmas in July
Investors may be starting to rotate away from the tech sector, if so here are three blue-chip stocks to buy. 
Via InvestorPlace
3 Blue-Chip Stocks to Buy If the Dow Crashes
Blue-chip stocks provide the ballast to keep a portfolio steady when markets go south as they offer reliable long-term returns. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.